Fragile X syndrome

182,263views

test

00:00 / 00:00

Fragile X syndrome

Exam 1 -AHN 548 -

Exam 1 -AHN 548 -

Anatomy of the breast
Anatomy clinical correlates: Breast
Mammary gland histology
Ovary histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the female reproductive system
Puberty and Tanner staging
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Breastfeeding
Stages of labor
Precocious puberty
Delayed puberty
Klinefelter syndrome
Turner syndrome
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Kallmann syndrome
Amenorrhea
Ovarian cyst
Premature ovarian failure
Ovarian torsion
Polycystic ovary syndrome
Krukenberg tumor
Sex cord-gonadal stromal tumor
Surface epithelial-stromal tumor
Germ cell ovarian tumor
Uterine fibroid
Endometriosis
Endometritis
Endometrial hyperplasia
Choriocarcinoma
Endometrial cancer
Cervical cancer
Pelvic inflammatory disease
Urethritis
Mastitis
Fibrocystic breast changes
Phyllodes tumor
Intraductal papilloma
Paget disease of the breast
Breast cancer
Gestational hypertension
Hyperemesis gravidarum
Preeclampsia & eclampsia
Gestational diabetes
Placenta previa
Placenta previa
Cervical incompetence
Placenta accreta
Placental abruption
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital syphilis
Congenital cytomegalovirus (NORD)
Neonatal conjunctivitis
Neonatal herpes simplex
Neonatal sepsis
Congenital rubella syndrome
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Ectopic pregnancy
Fetal alcohol syndrome
Uterine disorders: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Ovarian cysts and tumors: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Amenorrhea: Pathology review
Estrogens and antiestrogens
Androgens and antiandrogens
Uterine stimulants and relaxants
Progestins and antiprogestins
Aromatase inhibitors
Prolactinoma
Breast cancer: Clinical
Abnormal uterine bleeding: Clinical
Cervical cancer: Clinical
Genito-pelvic pain and penetration disorder
Sexual dysfunctions: Clinical
Infertility: Clinical
Amenorrhea: Clinical
Contraception: Clinical
Physical and sexual abuse
Sexual orientation and gender identity
Female sexual interest and arousal disorder
Orgasmic dysfunction
Ovarian cysts, cancer, and other adnexal masses: Clinical
Vulvovaginitis: Clinical
Hypertensive disorders of pregnancy: Clinical
Perinatal infections: Clinical
Gestational trophoblastic disease: Clinical
Routine prenatal care: Clinical
Abnormal labor: Clinical
Neonatal jaundice: Clinical
Streptococcus agalactiae (Group B Strep)
Neonatal hepatitis
Neonatal respiratory distress syndrome
Jaundice
Jaundice: Clinical
Enuresis
Nocturnal enuresis
Elimination disorders: Clinical
Biliary colic
Night terrors
ADHD: Information for patients and families (The Primary School)
Attention deficit hyperactivity disorder
Autism spectrum disorder
Fragile X syndrome
Precocious and delayed puberty: Clinical
Constitutional growth delay
Inheritance patterns
Mendelian genetics and punnett squares
Mitochondrial myopathy
Body dysmorphic disorder
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Cri du chat syndrome
DiGeorge syndrome
Williams syndrome
Neurofibromatosis
Marfan syndrome
Achondroplasia
Osteogenesis imperfecta
Craniosynostosis
Myelodysplastic syndromes
Cystic fibrosis
Cystic fibrosis: Pathology review
Cystic fibrosis: Clinical
Alport syndrome
Spinal muscular atrophy
Muscular dystrophy
Hemophilia
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Acute intermittent porphyria
Familial hypercholesterolemia
Gaucher disease (NORD)
Cleft lip and palate
Spina bifida
Developmental milestones: Clinical

Assessments

Flashcards

0 / 8 complete

USMLE® Step 1 questions

0 / 3 complete

High Yield Notes

5 pages

Flashcards

Fragile X syndrome

0 of 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

A 6-year-old adopted boy is brought to the physician to discuss his genetic testing results. The child had been having difficulties communicating with others in the classroom and was subsequently diagnosed with autism spectrum disorder and an intellectual disability. The genetic testing confirms a diagnosis of Fragile X syndrome. Which of the following family pedigrees represents this patient’s biological family history? (Arrows indicating the patient).  

External References

First Aid

2024

2023

2022

2021

Autism spectrum disorder p. 574

fragile X syndrome p. 60

Fragile X syndrome p. 60

chromosome association p. 62

dominant, inheritance of p. 57

Mitral valve prolapse p. 296

fragile X syndrome p. 60

Transcript

Watch video only

With Fragile X syndrome, sometimes just called Fragile X, the “X” refers to the X chromosome, where the disease gene is located.

The “fragile” refers to the fact that under a microscope, the X chromosome looks fragile or broken at the site of the mutation.

That’s because the chromatin which makes up the chromosome gets really condensed at that point.

Fragile X is a genetic disease that affects various organ systems.

Now, the gene for Fragile X is called FMR1, which stands for Fragile X mental retardation 1.

Mental retardation is the old term for intellectual disability, which is one of the key features of Fragile X syndrome.

The FMR1 gene has a triplet repeat, or trinucleotide repeat, which means that a group of three DNA nucleotides is repeated multiple times in a row.

In FMR1, it’s the nucleotides cytosine, guanine, and guanine, or CGG.

These CGGs are found in the 5’ untranslated region of FMR1.

A 5’ untranslated region is the part of DNA at the beginning of the gene that’s made into mRNA but not protein, and helps modulate gene expression.

Just upstream from the 5’ untranslated region is FMR1‘s promoter, the region that causes the gene to be transcribed to mRNA, which is usually turned on.

Expressed FMR1 mRNA gets translated into Fragile X mental retardation protein, or FMRP, and it helps in development of the brain and other tissues.

In Fragile X syndrome, there is a repeat expansion, meaning there’s an increased number of CGG repeats in the gene.

This repeat expansion is caused by slipped mispairing, which is where the enzyme DNA polymerase gets confused when copying a repetitive sequence.

DNA polymerase loses its place among the FMR1 triplet repeats and goes back to recopy what it already just copied.

This is like getting lost in a video and watch the same part over and over.

But since DNA polymerase is making copies, the effect is an increase, or expansion, of the number of repeats.

The normal number of CGG triplets is 5-44.

Alleles with 45 to 54 CGG repeats are called intermediate expansion alleles and they don’t cause any symptoms.

Alleles with 55 to 200 CGGs are called premutation alleles, and they can cause some mild symptoms.

Finally if an allele has over 200 CGGs, then it’s considered a full fragile X syndrome mutation and can make the chromosome take on its distinctive look.

Alleles can tend to get longer and longer as DNA polymerase becomes more and more unstable copying the longer stretches of repeats, so an intermediate expansion allele can become a premutation allele, and a premutation allele can expand to become a full fragile X syndrome mutation.

The repeat expansion attracts a DNA methylase enzyme to the site and causes the cytosines in the CGG repeats to become methylated.